Skip to Main Content

WASHINGTON — Supporters of a Senate-passed “right-to-try” bill that aims to help terminally ill patients gain access to experimental treatments are pushing for the House to act quickly on the measure — but key House leaders showed little interest in that push.

Sen. Ron Johnson (R-Wis.), who threatened to hold up a bipartisan and timely package of Food and Drug Administration policies in August in order to push his right-to-try legislation through the Senate, called on the House this week to pass his bill without changing a word. Any modifications in the House would force the Senate to reconsider the bill anew.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!